Cargando…

Avoidable waste of research related to inadequate methods in clinical trials

Objective To assess the waste of research related to inadequate methods in trials included in Cochrane reviews and to examine to what extent this waste could be avoided. A secondary objective was to perform a simulation study to re-estimate this avoidable waste if all trials were adequately reported...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yordanov, Youri, Dechartres, Agnes, Porcher, Raphaël, Boutron, Isabelle, Altman, Douglas G, Ravaud, Philippe
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group Ltd. 2015
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4372296/ https://www.ncbi.nlm.nih.gov/pubmed/25804210 http://dx.doi.org/10.1136/bmj.h809

Ejemplares similares

Avoidable waste of research related to outcome planning and reporting in clinical trials
por: Yordanov, Youri, et al.
Publicado: (2018)

Avoidable waste related to inadequate methods and incomplete reporting of interventions: a systematic review of randomized trials performed in Sub-Saharan Africa
por: Ndounga Diakou, Lee Aymar, et al.
Publicado: (2017)

Correction to: Avoidable waste related to inadequate methods and incomplete reporting of interventions: a systematic review of randomized trials performed in Sub-Saharan Africa
por: Ndounga Diakou, Lee Aymar, et al.
Publicado: (2018)

Patient-important outcomes in systematic reviews: Poor quality of evidence
por: Yordanov, Youri, et al.
Publicado: (2018)

Impact of an online writing aid tool for writing a randomized trial report: the COBWEB (Consort-based WEB tool) randomized controlled trial
por: Barnes, Caroline, et al.
Publicado: (2015)

Better prioritization to increase research value and decrease waste
por: Dechartres, Agnes, et al.
Publicado: (2015)

Inadequate description of educational interventions in ongoing randomized controlled trials
por: Pino, Cécile, et al.
Publicado: (2012)

Influence of trial sample size on treatment effect estimates: meta-epidemiological study
por: Dechartres, Agnes, et al.
Publicado: (2013)

Association between trial registration and treatment effect estimates: a meta-epidemiological study
por: Dechartres, Agnès, et al.
Publicado: (2016)

Geographical Representativeness of Published and Ongoing Randomized Controlled Trials. The Example of: Tobacco Consumption and HIV Infection
por: Ahmad, Nizar, et al.
Publicado: (2011)

Timing and Completeness of Trial Results Posted at ClinicalTrials.gov and Published in Journals
por: Riveros, Carolina, et al.
Publicado: (2013)

Methods of Blinding in Reports of Randomized Controlled Trials Assessing Pharmacologic Treatments: A Systematic Review
por: Boutron, Isabelle, et al.
Publicado: (2006)

Exclusion of patients with concomitant chronic conditions in ongoing randomised controlled trials targeting 10 common chronic conditions and registered at ClinicalTrials.gov: a systematic review of registration details
por: Buffel du Vaure, Céline, et al.
Publicado: (2016)

Public availability of results of observational studies evaluating an intervention registered at ClinicalTrials.gov
por: Baudart, Marie, et al.
Publicado: (2016)

Impact of single centre status on estimates of intervention effects in trials with continuous outcomes: meta-epidemiological study
por: Bafeta, Aïda, et al.
Publicado: (2012)

Risk of bias in observational studies using routinely collected data of comparative effectiveness research: a meta-research study
por: Nguyen, Van Thu, et al.
Publicado: (2021)

Applicability and generalisability of the results of systematic reviews to public health practice and policy: a systematic review
por: Ahmad, Nizar, et al.
Publicado: (2010)

Incorporation of assessments of risk of bias of primary studies in systematic reviews of randomised trials: a cross-sectional study
por: Hopewell, Sally, et al.
Publicado: (2013)

Knee Arthroplasty: Disabilities in Comparison to the General Population and to Hip Arthroplasty Using a French National Longitudinal Survey
por: Dechartres, Agnes, et al.
Publicado: (2008)

Disagreements in risk of bias assessment for randomised controlled trials included in more than one Cochrane systematic reviews: a research on research study using cross-sectional design
por: Bertizzolo, Lorenzo, et al.
Publicado: (2019)

Evidence for Treatment-by-Biomarker interaction for FDA-approved Oncology Drugs with Required Pharmacogenomic Biomarker Testing
por: Vivot, Alexandre, et al.
Publicado: (2017)

Blockchain protocols in clinical trials: Transparency and traceability of consent
por: Benchoufi, Mehdi, et al.
Publicado: (2018)

Effectiveness and Medicoeconomic Evaluation of Home Monitoring of Patients With Mild COVID-19: Covidom Cohort Study
por: Jaulmes, Luc, et al.
Publicado: (2023)

Quality of Reporting of Bioequivalence Trials Comparing Generic to Brand Name Drugs: A Methodological Systematic Review
por: van der Meersch, Amélie, et al.
Publicado: (2011)

Accuracy in detecting inadequate research reporting by early career peer reviewers using an online CONSORT-based peer-review tool (COBPeer) versus the usual peer-review process: a cross-sectional diagnostic study
por: Chauvin, Anthony, et al.
Publicado: (2019)

Reporting of sample size calculation in randomised controlled trials: review
por: Charles, Pierre, et al.
Publicado: (2009)

Outcomes in Registered, Ongoing Randomized Controlled Trials of Patient Education
por: Pino, Cécile, et al.
Publicado: (2012)

Assessment of transparency and selective reporting of interventional trials studying colorectal cancer
por: Pellat, Anna, et al.
Publicado: (2022)

Comparison of serious adverse events posted at ClinicalTrials.gov and published in corresponding journal articles
por: Tang, Eve, et al.
Publicado: (2015)

Availability of Results of Trials Studying Pancreatic Adenocarcinoma over the Past 10 Years
por: Pellat, Anna, et al.
Publicado: (2022)

Differential Globalization of Industry- and Non-Industry–Sponsored Clinical Trials
por: Atal, Ignacio, et al.
Publicado: (2015)

Reporting Methods of Blinding in Randomized Trials Assessing Nonpharmacological Treatments
por: Boutron, Isabelle, et al.
Publicado: (2007)

Reply: COVID-19 drug research and the cohort multiple randomised controlled trial design
por: Porcher, Raphaël, et al.
Publicado: (2022)

Reporting of statistically significant results at ClinicalTrials.gov for completed superiority randomized controlled trials
por: Dechartres, Agnes, et al.
Publicado: (2016)

Course of post COVID-19 disease symptoms over time in the ComPaRe long COVID prospective e-cohort
por: Tran, Viet-Thi, et al.
Publicado: (2022)

Impact of sending email reminders of the legal requirement for posting results on ClinicalTrials.gov: cohort embedded pragmatic randomized controlled trial
por: Maruani, Annabel, et al.
Publicado: (2014)

The VEPRO trial: A cross-over randomised controlled trial comparing 2 progressive lenses for patients with presbyopia
por: Boutron, Isabelle, et al.
Publicado: (2008)

Feasibility of individual patient data meta-analyses in orthopaedic surgery
por: Villain, Benoit, et al.
Publicado: (2015)

Comparison of Estimates between Cohort and Case–Control Studies in Meta-Analyses of Therapeutic Interventions: A Meta-Epidemiological Study
por: Lanza, Amy, et al.
Publicado: (2016)

Impact of the Nutri-Score front-of-pack nutrition label on purchasing intentions of individuals with chronic diseases: results of a randomised trial
por: Egnell, Manon, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_8h0lje4c1ke3q4b1rhj7jdj409